Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The CATT Trial: Cost-effectiveness of a Smartphone Application for Tinnitus Treatment

NCT: NCT05245318 · COMPLETED

NCT IDNCT05245318
StatusCOMPLETED
Start Date2022-03-01
Completion2025-11-27
SponsorHasselt University (OTHER)
First posted
Last updated

Brief Summary

The twofold aim of this single-blind two-arm 1:1 randomised control trial is to examine if the treatment effect and cost-effectiveness of a smartphone application, designed to increase therapy compliance and provide tinnitus counselling, as part of a blended physiotherapy program, is, as hypothesised, as good as or better in comparison to standard clinical care.

Frequently Asked Questions

What is The CATT Trial: Cost-effectiveness of a Smartphone Application for Tinnitus Treatment?

The CATT Trial: Cost-effectiveness of a Smartphone Application for Tinnitus Treatment is a clinical trial registered under NCT05245318. Current status: COMPLETED.

What is the status of NCT05245318?

The current status of NCT05245318 (The CATT Trial: Cost-effectiveness of a Smartphone Application for Tinnitus Treatment) is: COMPLETED.

When did The CATT Trial: Cost-effectiveness of a Smartphone Application for Tinnitus Treatment start?

The CATT Trial: Cost-effectiveness of a Smartphone Application for Tinnitus Treatment started on 2022-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑